Back to Menu
Duodenal Cancer Treatment Modalities
1.Pancreaticoduodenectomy
The standard curative procedure. The resection includes the pancreatic head and duodenum, with regional lymph node dissection; attention should be paid to the risk of pancreatic fistula.
2.Segmental duodenal resection
Suitable for early tumors in the horizontal (third) or ascending (fourth) portion of the duodenum. It preserves the pancreas and biliary tract and is less traumatic, but negative margins must be ensured.
3.Endoscopic mucosal resection (EMR)
Suitable for well-differentiated intramucosal carcinoma <2 cm. It is minimally invasive with rapid recovery, but close surveillance is required to prevent recurrence.
4.Minimally invasive surgery
Laparoscopic or robot-assisted pancreaticoduodenectomy is associated with less trauma and faster recovery, and requires an experienced multidisciplinary surgical team.
5.Chemotherapy regimens
Adjuvant chemotherapy may include FOLFOX or capecitabine, while advanced disease may be treated with FOLFIRINOX to eradicate microscopic residual disease.
6.Radiotherapy techniques
Used for preoperative downstaging, postoperative adjuvant therapy, or palliative treatment in advanced disease. Precision radiotherapy (IMRT/SBRT) helps spare normal tissues.
7.Targeted therapy strategies
For tumors with actionable alterations such as HER2 or NTRK gene fusions, target testing is required; targeted agents may be used for advanced or recurrent disease.
8.Palliative surgery
Gastrointestinal or biliary-enteric bypass can relieve obstruction and improve quality of life, and may be combined with stent placement.
Conclusion
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that duodenal cancer is occult in presentation and rapidly progressive, posing a serious threat to life. Early diagnosis and standardized treatment are key to improving survival. Pancreaticoduodenectomy is currently the only potentially curative option. MDT-based comprehensive management can substantially improve prognosis. High-risk populations should undergo regular esophagogastroduodenoscopy screening, and individuals with symptoms should seek prompt medical evaluation.
Duodenal Cancer Treatment Modalities
1.Pancreaticoduodenectomy
The standard curative procedure. The resection includes the pancreatic head and duodenum, with regional lymph node dissection; attention should be paid to the risk of pancreatic fistula.
2.Segmental duodenal resection
Suitable for early tumors in the horizontal (third) or ascending (fourth) portion of the duodenum. It preserves the pancreas and biliary tract and is less traumatic, but negative margins must be ensured.
3.Endoscopic mucosal resection (EMR)
Suitable for well-differentiated intramucosal carcinoma <2 cm. It is minimally invasive with rapid recovery, but close surveillance is required to prevent recurrence.
4.Minimally invasive surgery
Laparoscopic or robot-assisted pancreaticoduodenectomy is associated with less trauma and faster recovery, and requires an experienced multidisciplinary surgical team.
5.Chemotherapy regimens
Adjuvant chemotherapy may include FOLFOX or capecitabine, while advanced disease may be treated with FOLFIRINOX to eradicate microscopic residual disease.
6.Radiotherapy techniques
Used for preoperative downstaging, postoperative adjuvant therapy, or palliative treatment in advanced disease. Precision radiotherapy (IMRT/SBRT) helps spare normal tissues.
7.Targeted therapy strategies
For tumors with actionable alterations such as HER2 or NTRK gene fusions, target testing is required; targeted agents may be used for advanced or recurrent disease.
8.Palliative surgery
Gastrointestinal or biliary-enteric bypass can relieve obstruction and improve quality of life, and may be combined with stent placement.
Conclusion
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that duodenal cancer is occult in presentation and rapidly progressive, posing a serious threat to life. Early diagnosis and standardized treatment are key to improving survival. Pancreaticoduodenectomy is currently the only potentially curative option. MDT-based comprehensive management can substantially improve prognosis. High-risk populations should undergo regular esophagogastroduodenoscopy screening, and individuals with symptoms should seek prompt medical evaluation.